Trials / Completed
CompletedNCT00959439
Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg)
A Comparative Bioavailability Study of Naproxen Delayed-Release Tablets, 375mg.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to demonstrate the relative bioavailability of Naproxen delayed-release tablets (375 mg).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.) | |
| DRUG | Naproxen (EC-Narosyn) Delayed Release Tables, 375 (Syntex (USA), Inc.) |
Timeline
- Start date
- 2002-03-01
- Primary completion
- 2002-05-01
- Completion
- 2002-05-01
- First posted
- 2009-08-14
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00959439. Inclusion in this directory is not an endorsement.